{"ORPHApacket":[{"ORPHApacketID":"79298","date":"2019-12-06 09:00:58","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"79298","Name":[{"lang":"en","label":"Diazoxide-resistant focal hyperinsulinism"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79298","DisorderType":[{"Name":[{"lang":"en","label":"Clinical group"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Diazoxide-resistant hyperinsulinism"}],"ORPHA":"276585","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_276585"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Diazoxide-resistant focal hyperinsulism (DRFH) is a form of diazoxide-resistant hyperinsulinism (see this term) characterized by recurrent episodes of profound hypoglycemia caused by an excessive\/ uncontrolled insulin secretion (inappropriate for the level of glycemia) due to a focal adenomatous hyperplasia of pancreas, that is unresponsive to medical treatment with diazoxide, necessitating complete excision of the focal lesion."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Hyperinsulinemic hypoglycemia, diazoxide-resistant focal form"}]}]}]}